Filing Details

Accession Number:
0000950170-24-105167
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-09-10 16:30:11
Reporting Period:
2024-09-06
Accepted Time:
2024-09-10 16:30:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1842939 Carmell Corp CTCX Surgical & Medical Instruments & Apparatus (3841) 861645738
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1997294 M. Scott Frisch C/O Carmell Corporation
2403 Sidney Street, Suite 300
Pittsburgh PA 15203
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-09-06 1,009 $0.51 7,598 No 4 P Indirect By Carmell Insiders LLC
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Carmell Insiders LLC
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 20,821 Direct
Footnotes
  1. The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC ("LLC"). The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information). The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (19.1%), Scott Frisch (15.3%), Kathryn Gregory (26.4%), Gilles Spenlehauer (15.3%), and Patrick Sturgeon (23.9%). The total amount invested in the LLC by these members was $130,750 as of the date of his filing. The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC.
  2. The shares beneficially owned by the Reporting Person include 20,821 shares of common stock that may be acquired pursuant to the exercise of stock options within 60 days of the date of this filing.